New AI-based, non-invasive diagnostic tool enables accurate brain tumor diagnosis, surpassing current methods
Medical Xpress: Radiology
MARCH 11, 2024
Jointly developed by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group and the Bellvitge University Hospital's Neuroradiology Unit, the Diagnosis in Susceptibility Contrast Enhancing Regions for Neuroncology (DISCERN) is an open-access deep learning tool based on the training of patterns using artificial intelligence (..)
Let's personalize your content